Remove 2018 Remove Data Remove Extraction Remove Safety
article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52
article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. I am very hopeful that this data will allow the FDA to regulate these popular CBD products.”.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act

Cannabis Law Report

The following is a statement from CRN President & CEO Steve Mister: “CRN is extremely disappointed to learn that FDA rejected NDI notifications for full-spectrum hemp extract containing CBD submitted earlier this year by supplement manufacturers Charlotte’s Web and Irwin Naturals. In December 2019, CRN and FDA met to discuss these issues.

article thumbnail

U.S. Hemp Roundtable Statement Regarding FDA NDIN Rejection Letters

Cannabis Law Report

Hemp Roundtable is deeply disappointed to witness FDA’s rejection of two dietary ingredient notifications (NDINs) recently submitted for full spectrum hemp extracts. USHR-Statement-on-FDA-NDIN-Rejection-Letters.

Hemp 105
article thumbnail

Answer of the Day for Jul 18, 2022

TheAnswerPage

Are CBD-rich extracts more effective at reducing seizures compared to purified CBD products? The analysis attempted to establish the safety and efficacy of the CBD products, and to determine if there is enough evidence to assume any difference in efficacy between CBD-rich extracts compared to purified CBD products.

article thumbnail

The Ongoing Work of Cannabis Regulations Following the California Governor Recall Vote: Week in Review

SpeedWeed

NDIN notifications are submissions intended to satisfy the FDA that the dietary ingredient—full spectrum hemp extract, in this instance—is safe for the intended use, typically based on a demonstrated history of safe use or clinical studies relevant to the ingredient. Still About Safety. A Legislative Fix? . Not About Enforcement.

Data 79
article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59